ResearchSafe

Cartalax (Cartalax (Ala-Glu-Asp-Gly Cartilage Bioregulator))

Category: Pain & Inflammation. Status: Research compound (peptide bioregulator).

A short synthetic peptide bioregulator from the Khavinson family targeted at cartilage and connective/musculoskeletal tissue. Used in the bioregulator community for joint and cartilage support in short repeated courses.

How it works

As a signal peptide (Ala-Glu-Asp-Gly), it is proposed to regulate gene expression in chondrocytes and connective tissue, supporting cartilage matrix maintenance and anti-inflammatory tissue signaling.

Key facts

  • Molecular weight: ~390 Da
  • Half-life: Short (peptide)
  • Bioavailability: Oral (encapsulated) or subcutaneous
  • Storage: Room temperature (capsules) or refrigerate (injectable).

Dosing overview

  • Typical dose: ~1-2 capsules/day or short injectable courses
  • Frequency: Once daily
  • Duration: 10-30 day courses
  • Route: Oral capsule or subcutaneous

Protocol notes

  • Taken as short repeatable courses (often 10-30 days), a few times per year.
  • Oral encapsulated forms are taken once daily on an empty stomach.
  • Often paired with healing peptides in joint-support protocols.

Reported benefits

  • Cartilage/joint tissue support
  • Connective tissue maintenance (proposed)
  • Anti-inflammatory tissue signaling
  • Short course-based protocol

Possible side effects

  • Limited Western clinical data
  • Injection site reactions (injectable)
  • Unknown long-term effects

Research

  • Cartilage peptide bioregulators (2015): Reported to support chondrocyte function and cartilage tissue in regional research studies.

Community reviews of Cartalax

Rated 4.7 out of 5 from 3 community reviews by ResearchSafe members.

  • morning_protocol rated it 4/5 - Worth adding to the protocol: Cartalax has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
  • bloodwork_brett rated it 5/5 - Noticed clear benefits within weeks: Added Cartalax to my protocol about 6 weeks ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • careful_claire rated it 5/5 - Genuinely effective after 2 weeks: Been using Cartalax for about 2 weeks and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.

Compare Cartalax

Community discussions about Cartalax

Research and educational reference only. Not medical advice.